Expression of Interleukin-10 mRNA in Children with Different Clinical Types of Henoch-Schonlein Purpura Nephritis

吴元俊,陈荣华,陈吉庆,张爱华,蔡毅
DOI: https://doi.org/10.3969/j.issn.1007-4368.2002.02.006
2002-01-01
Abstract:Objective:To investigate the role of interleukin-10 (IL-10) in the pathogenesis of different clinical types Henoch-Schonlein purpu ra nephritis (HSPN). Methods:The IL-10 protein was determined by ELIS A and the expression of IL-10 mRNA was measured by reverse transcription-polym eras e chain reaction (RT-PCR) in phytohemagglutinin (PHA)-stimulating peripheral b lood mononuclear cells (PBMCS) in 40 children with HSPN during their acute phase and remission stage. Results:①The levels of IL-10 mRNA and protein w ere significantly increased in patients in acute phase compared with controls [ (0 .48±0.12) vs (0.39±0.10) and (1023.90±158.78) pg/ml vs (895.51±141.06) p g/ml ; %P%0.01 and 0.05 respectively], while in remission stage the levels of IL -10 decr eased to normal levels [(0.42±0.13) vs (0.39±0.10) and (941.25±165.36) pg/ml vs (895.51±141.06) pg/ml; %P%0.05 for both]. ②The IL-10 mRNA and pro tein of HSPN p atients in acute phase with proteinuria, nephrotic syndrome or acute glomerulone phritis syndrome was signficantly higher than that in controls. There was no sig nificant difference between the acute phase of HSPN patients with isolated hemat uria and the controls. Conclusion:The results suggested that the expre ssion of IL-10 in PBMC was correlated to clinical type of HSPN. IL-10 has prot ective action in the pathogenesis of HSPN.
What problem does this paper attempt to address?